Your session is about to expire
← Back to Search
Universal Basic Income for Health Care Utilization
N/A
Recruiting
Research Sponsored by University of Arkansas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Study Summary
This trial will test if UBI can increase healthcare access for chronically-ill, low-income Black men, who often face difficult barriers to care.
Who is the study for?
This trial is for Black men, aged 45+ or 25+ if HIV-positive, with at least one chronic health condition. They must have been recently released from an Arkansas correctional facility (for half the sample), speak English, consent to share personal data, and plan to stay in central Arkansas for the study duration.Check my eligibility
What is being tested?
The study tests whether a Universal Basic Income of $500 per month for six months can increase healthcare utilization among chronically-ill, low-income Black men by providing financial support and potentially improving their personal agency and social connections.See study design
What are the potential side effects?
Since this trial involves a financial intervention rather than a medical treatment, there are no direct physical side effects. However, changes in income could indirectly affect stress levels or decision-making.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Healthcare service utilization
Secondary outcome measures
Greater income/improved self-esteems/reduced stress/affirmed personal agency/improved mental health & more time for health promoting behaviors
Improved social connections/ greater receipt of social support/greater ability to pursue educational & employment opportunities
Increased enrollment in & use of social service and healthcare programs and increased voting
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Participants in Arm 2 will receive a monthly UBI stipend of $500 for 6 months. Study staff will explain that UBI payments will continue for 6 months and that the UBI payments will be suspended if an individual is reincarcerated (e.g. the participant will not receive UBI payments to their ClinCard during months of incarceration and will not receive additional months post-release from incarceration). Participants will receive their monthly UBI payment, along with all study-related compensation for completing baseline and follow-up assessments, through a ClinCard, which is a loadable debit card with an ID number unique to the participant. The UBI will be loaded to the participant's ClinCard on the first day of each month.
Group II: ControlActive Control1 Intervention
All participants will receive the following: 1) a ClinCard and instructions for completing a weekly financial journal to record participants' spending patterns and social needs during the first 6 months of the study; 2) materials about financial literacy and community-based resources that provide support to low-income individuals; 3) description and instructions for follow-up assessments and check-ins; 4) a copy of signed medical release, consent, and HIPAA forms; 5) respondent-driven sampling referral cards; 6) 3 study referral cards, and 7) information about voter registration services provided through the Pulaski County Circuit and County Clerk's Office (https://www.pulaskiclerk.com/voter-registration/). Participants will be provided information about the importance of voting, restoration of voting rights, and the process of voting and sealing records.
Find a Location
Who is running the clinical trial?
University of ArkansasLead Sponsor
486 Previous Clinical Trials
149,903 Total Patients Enrolled
Ashley E Williams, MHSStudy DirectorUniversity of Arkansas
Ashley Williams, MSHSStudy DirectorUniversity of Arkansas
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am at least 45 years old.I was assigned male at birth.
Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there availability to participate in this experiment?
"The trial, which was initially announced on April 1st 2023 and revised lastly on the 7th of that same month, is presently searching for participants according to clinicaltrials.gov."
Answered by AI
What do researchers hope to discover through this clinical investigation?
"This 5-year clinical trial strives to increase healthcare utilization among participants. Secondary objectives involve measuring medication adherence, HIV care uptake and engagement, as well as reducing the prevalence of unsafe behaviours such as unprotected sex or substance abuse."
Answered by AI
How many subjects are participating in this research endeavor?
"Affirmative. Perusal of the clinicaltrials.gov database reveals that this medical trial, originally posted on April 1st 2023, is presently recruiting. 530 candidates need to be sourced from a single location for inclusion in the study."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger